Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer
- 1 January 2005
- journal article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 44 (4), 355-361
- https://doi.org/10.1080/02841860510029806
Abstract
To determine the accuracy of patient recall of disease-specific symptoms and quality of life (QoL) in men treated with external beam radiotherapy (EBRT) for localized prostate cancer (LPC). One hundred and five patients enrolled in a prospective study of bladder, bowel, and sexual function, and QoL after radiotherapy for PC were requested to assess their baseline QoL and symptoms before treatment. About one year (mean 14.1 months; range 7-21 months) after treatment, they were asked to recall their baseline QoL and symptoms. Baseline and recall data were compared. Both QoL and symptoms were measured with established instruments, the European Organization for Research and Treatment of Cancer (EORTC) group's QLQ-C30 questionnaire and the Prostate Cancer Symptom Scale (PCSS). Eighty-five of 105 patients (81%) returned the questionnaires. Altogether, the recall of symptoms was poor. Urinary and intestinal symptoms were scored worse at recall than they had actually been at baseline. By contrast, patients tended to remember their baseline sexual function as having been better than it had actually been. The recall of QoL was good. The only QoL domain with a difference between recall and baseline data was that measured in the global health status/QoL scale of the QLQ-C30 questionnaire. The effect did not vary with age or time of follow-up since baseline. Men treated with EBRT for LPC do not accurately recall their pretreatment symptoms or QoL about 1 year after treatment. The accuracy of recall was not affected by time since EBRT (7-21 months). Age did not influence the recall bias. More precise data on impairments in QoL after EBRT in patients with LPC are therefore obtained from baseline and prospective follow-up studies.Keywords
This publication has 24 references indexed in Scilit:
- Prostate‐specific antigen relapse‐free survival in patients with localized prostate cancer treated by brachytherapyBJU International, 2004
- BOWEL FUNCTION AND BOTHER AFTER TREATMENT FOR EARLY STAGE PROSTATE CANCER: A LONGITUDINAL QUALITY OF LIFE ANALYSIS FROM CaPSUREJournal of Urology, 2004
- Quality of Life after Radical Prostatectomy or Watchful WaitingNew England Journal of Medicine, 2002
- A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2002
- The EORTC Core Quality of Life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapyEuropean Journal Of Cancer, 1995
- Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of lifeInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Psychometric Validation of the Eortc Core Quality of Life Questionnaire, 30-Item Version and A Diagnosis-Specific Module for Head and Neck Cancer PatientsActa Oncologica, 1992
- Underreporting by cancer patients: The case of response-shiftSocial Science & Medicine, 1991
- NATURAL HISTORY OF LOCALISED PROSTATIC CANCERThe Lancet, 1989
- Coefficient alpha and the internal structure of testsPsychometrika, 1951